|
Volumn 30, Issue 6, 2014, Pages 667-670
|
Risk stratification and selection for statin therapy: Going beyond framingham
|
Author keywords
[No Author keywords available]
|
Indexed keywords
APOLIPOPROTEIN B;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
AMBIGUITY;
ANKLE BRACHIAL INDEX;
ARTICLE;
ATHEROSCLEROTIC CARDIOVASCULAR DISEASE;
CARDIAC IMAGING;
CLINICAL DECISION MAKING;
CLINICAL FEATURE;
CORONARY ARTERY CALCIUM SCORE;
DYSLIPIDEMIA;
ELECTROCARDIOGRAPHY;
FAMILY HISTORY;
FRAMINGHAM RISK SCORE;
HUMAN;
PATIENT PREFERENCE;
PRACTICE GUIDELINE;
PRIMARY PREVENTION;
RISK ASSESSMENT;
STRESS;
ANKLE BRACHIAL INDEX;
ATHEROSCLEROSIS;
BIOLOGICAL MARKERS;
C-REACTIVE PROTEIN;
CARDIOVASCULAR DISEASES;
CAROTID ARTERIES;
CAROTID INTIMA-MEDIA THICKNESS;
DECISION MAKING;
DYSLIPIDEMIAS;
ELECTROCARDIOGRAPHY;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
LIPOPROTEINS;
METABOLIC SYNDROME X;
PATIENT SELECTION;
RISK ASSESSMENT;
|
EID: 84901430168
PISSN: 0828282X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.cjca.2014.03.006 Document Type: Article |
Times cited : (4)
|
References (5)
|